Research Article
Phenotypic and Molecular Characterization of β-Lactamases among Enterobacterial Uropathogens in Southeastern Nigeria
Table 3
Antibiotic susceptibility pattern of E. coli (n = 58).
| S/no | Antibiotics | No. of isolates (%) | Resistant | Intermediate | Susceptible n |
| 1 | Cefpodoxime (CPD) | 35 (60.34) | 19 (32.76) | 4 (6.90) | 2 | Ceftriaxone (CTR) | 0 (0) | 10 (17.24) | 48 (82.76) | 3 | Aztreonam (AT) | 1 (1.72) | 36 (62.07) | 21 (36.21) | 4 | Cefotaxime (CTX) | 8 (13.79) | 33 (56.90) | 17 (29.31) | 5 | Ceftazidime (CAZ) | 1 (1.72) | 34 (58.62) | 23 (39.66) | 6 | Meropenem (MRP) | 9 (15.52) | 7 (12.06) | 42 (72.41) | 7 | Cefoxitin (CX) | 3 (5.17) | 11 (18.97) | 44 (75.86) | 8 | Ofloxacin (OF) | 4 (6.90) | 4 (6.90) | 50 (86.21) | 9 | Ciprofloxacin (CIP) | 4 (6.90) | 10 (17.24) | 44 (75.86) | 10 | Norfloxacin (NX) | 5 (8.62) | 1 (1.72) | 51 (87.93) | 11 | Levofloxacin (LE) | 4 (6.90) | 0 (0) | 54 (93.10) | 12 | Cotrimoxazole (COT) | 29 (50) | 1 (1.72) | 26 (44.83) | 13 | Gentamicin (GEN) | 6 (10.34) | 6 (10.34) | 45 (77.59) | 14 | Amoxicillin (AMX) | 16 (27.59) | 3 (5.17) | 20 (34.48) |
|
|